News
Important Only
UBS examines hit to funds from $500 million First Brands exposure
ZURICH, Oct 8 (Reuters) - UBS UBSG.S said on Wednesday it was examining the impact of the bankruptcy of First Brands on several of its investment funds, with the Swiss bank exposed to the tune of more than $500 million to the collapsed U.S. auto parts supplier.Switzerland's biggest lender has ex...Reuters
9 minutes ago
Rubio to attend Paris meeting on Gaza transition, sources say
PARIS, Oct 8 (Reuters) - U.S. Secretary of State Marco Rubio is expected to attend a ministerial meeting to be held on Thursday in Paris with European, Arab and other states to discuss Gaza's post-war transition, three diplomatic sources said on Wednesday.The meeting, to be held in parallel with...Reuters
12 minutes ago
German cartel office investigating Temu over merchant price influencing
BERLIN, Oct 8 (Reuters) - Germany's cartel office has initiated proceedings into Temu to examine whether the Chinese discount e-commerce platform is influencing merchants' pricing, it said on Wednesday. "We are investigating the suspicion that Temu could impose inadmissible requirements ...Reuters
13 minutes ago
Trump calls for Chicago mayor, Illinois governor to be jailed
By Brendan O'Brien, Susan Heavey and Andy Sullivan CHICAGO/WASHINGTON, Oct 8 (Reuters) - U.S. President Donald Trump on Wednesday called for jailing Chicago's mayor and Illinois' governor, both Democrats, as his administration prepared to deploy military troops to the streets of the t...Reuters
15 minutes ago
U.S. RESEARCH ROUNDUP- AGCO, Caterpillar, United Rentals
Oct 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AGCO, Caterpillar and United Rentals, on Wednesday. HIGHLIGHTS* AGCO Corp AGCO.N: Jefferies cuts target price to $125 from $135* Caterpillar Inc CAT.N: Jefferies rais...Reuters
17 minutes ago
WHO asks India to check whether cough syrup linked to child deaths was exported
Toxic cough syrup linked to deaths of 17 children under fiveTests show Indian drugmakers failed testing normsGujarat state finds deficiencies at two other cough syrup makersWHO asks India to clarify if contaminated syrup was exportedBy Krishna N. Das and Praveen Paramasivam NEW DELHI, CHENNAI, Oc...Reuters
19 minutes ago
German cartel office investigating Temu over merchant price influencing
BERLIN, Oct 8 (Reuters) - Germany's cartel office has initiated proceedings into Temu to examine whether the Chinese discount e-commerce platform is influencing merchants' pricing, it said on Wednesday. "We are investigating the suspicion that Temu could impose inadmissible requirements ...Reuters
26 minutes ago
Trump calls for Chicago mayor, Illinois governor to be jailed
CHICAGO/WASHINGTON, Oct 8 (Reuters) - U.S. President Donald Trump on Wednesday called for Chicago Mayor Brandon Johnson and Illinois Governor JB Pritzker to be jailed, accusing the two Democrats of failing to protect federal immigration officers without offering any evidence. Trump's comments, p...Reuters
31 minutes ago
Invesco Ltd - Aqua Acquisition Sub LLC (An Indirect Wholly-Owned Subsidiary Of Qualcomm Incorporated) Public Dealing Disclosure
Oct 8 (Reuters) - Qualcomm Inc QCOM.O:INVESCO LTD.: INVESCO LTD: FORM 8.3 - AQUA ACQUISITION SUB LLC (AN INDIRECT WHOLLY-OWNED SUBSIDIARY OF QUALCOMM INCORPORATED); PUBLIC DEALING DISCLOSUREReuters
33 minutes ago
Leidos Holdings Signs Contract With Kazaeronavigatsia To Modernize Kazakhstan Air Traffic Control
Oct 8 (Reuters) - Leidos Holdings Inc LDOS.N:LEIDOS HOLDINGS - SIGNS CONTRACT WITH KAZAERONAVIGATSIA TO MODERNIZE KAZAKHSTAN AIR TRAFFIC CONTROLLEIDOS HOLDINGS: AGREEMENT HAS 19-YEAR PERIOD OF PERFORMANCE AND INCLUDES WORK AT FOUR CONTROL CENTERS & 21 TOWERS ACROSS THE COUNTRYReuters
35 minutes ago
Rigel Announces First Patient Enrolled In Dose Expansion Phase Of 1B Study Of R289 In Patients With Lower-Risk MDS
Oct 8 (Reuters) - Rigel Pharmaceuticals Inc RIGL.O:RIGEL ANNOUNCES FIRST PATIENT ENROLLED IN THE DOSE EXPANSION PHASE OF ITS PHASE 1B STUDY OF R289 IN PATIENTS WITH LOWER-RISK MDSReuters
36 minutes ago
Nasus Pharma Announces Expanded Agreement To Support Development And Commercialization Of Ns002 Intranasal Epinephrine Program
Oct 8 (Reuters) - Nasus Pharma Ltd NSRX.A:NASUS PHARMA ANNOUNCES EXPANDED AGREEMENT TO SUPPORT DEVELOPMENT AND COMMERCIALIZATION OF NS002 INTRANASAL EPINEPHRINE PROGRAMReuters
37 minutes ago
